New Kappa-Opioid Receptor Agonist Curbs Pain, Avoids Side Effects
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence - Biological Psychiatry
Antagonists of the kappa opioid receptor - ScienceDirect
Opioids in cancer: The κ‑opioid receptor (Review)
Molecules | Free Full-Text | Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic
A Kappa Opioid Receptor Agonist Blocks Bone Cancer Pain Without Altering Bone Loss, Tumor Size, or Cancer Cell Proliferation in a Mouse Model of Cancer-Induced Bone Pain - The Journal of Pain
Mu Agonist Opioids and Kappa Opioids | Download Table
A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics - ScienceDirect
Figure 2 from Development of κ opioid receptor antagonists. | Semantic Scholar
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
κ-Opioid Receptor (KOP) | 7TM Antibodies
Table II from Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review. | Semantic Scholar
Innovation – Cara Therapeutics
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Understanding opioids in veterinary medicine
Topical administration of the kappa opioid receptor agonist nalfurafine suppresses corneal neovascularization and inflammation | Scientific Reports
Opioid Receptor | kappa, mu Opioid Receptor
Untangling the complexity of opioid receptor function | Neuropsychopharmacology